biochemical improvement but no increase in quadriceps strength (Isenberg et al. 1982) .
The polymyalgic-like episodesevere central joint pain and morning stiffnessis also interesting. The normal ESR and negative response to systemic steroids excluded polymyalgia rheumatica, and it appears that osteomalacia should be included in the differential diagnosis of this condition.
References Albright F & Reifenstein E C (1948) Hubbard et al. (1982) . We now report the successful use of TBI to induce prolonged remission in a patient whose disease had not responded to conventional therapy.
Case report
Early in 1979, a 49-year-old metallurgist developed a febrile illness with some pain in the small joints of both hands. A week later he began to notice difficulty with walking and rising from a chair, and by the following week he could not get out of a bath without help. At his local hospital a diagnosis of polymyositis was made on the basis of elevated serum muscle enzymes, electromyography and muscle biopsy. In the past he had noticed grittiness of his eyes and described classical Raynaud's phenomonen. A search for occult malignancy was negative.
His initial response to prednisolone was good, but because of a relapse in 1979 azathionrine was added. This induced a.prolonged remission lasting until 1981, when a further 'flare' occurred. An increase in his dose of prednisolone failed to control this, and intravenous methotrexate was started (25 mg weekly increasing to 50 mg) with little benefit.
He was referred to the Rheumatology Unit at Hammersmith Hospital for consideration of treatment with TBI. On admission he was febrile, and serial measurements of peak flow showed a gradual decline in ventilatory function. There was a slight anaemia (Hb 10.1 g/dl and his ESR was 90mm/h. The serum muscle enzymes were elevated, with a creatinine phosphokinase (CPK) of 1200 iu/l (normal 170) and myoglobinuria. A needle muscle biopsy showed an intense inflammatory cell infiltrate with necrosis. Anti-Jo-lantibody was detected in his serum and a chest radiograph showed patchy shadowing consistent with pulmonary fibrosis.
In view of his profound weakness and declining clinical condition a trial of TBI was given (200 cGy over 10 weeks). The response was dramatic, with a fall in CPK two weeks after starting treatment, paralleled by development of a lymphopenia and improvement in muscle strength measured by strain-gauge myometry (Edwards & McDonnel 1974) . A month later he left hospital and was able to return to work. Eighteen months later he remains well on 5 mg prednisolone daily, although his CPK has remained persistently elevated (1000-2000 iu/l).
Discussion
Muscle destruction in myositis probably involves a subset of cytotoxic lymphocytes (Daukins & Mastaglia 1973) , the role of myositis-specific autoantibodies being unclear (Nishikai & Reichlin 1980 , Matthews & Bernstein 1983 ). Irradiation has diverse effects on lymphocytes but is immunosuppressive. A lymphopenia occurred in this patient within two weeks of starting treatment with TBI, concomitant with improvement in muscle strength and a fall in CPK.
The long-term benefit of TBI is uncertain. In one other patient thus treated (Hubbard et should be compared to those from cytotoxic therapy (Casciato & Scoci 1979) . Bone marrow toxicity is unavoidable and may be potentiated by previous cytotoxic therapy or irradiation, and this may be a life-threatening complication (Morgan et al. 1985) if caution in planning dosage is not observed. Anti-Jo-l-antibody, an autoantibody directed against histidyl-t-RNA synthetase (Matthews & Bernstein 1983) , is specific for myositis and was found in 25% of patients with dermatomyositis or polymyositis seen at Hammersmith Hospital. It is not found in childhood or malignancy-associated myositis, but does seem to, 'label' a subset of patients with interstitial lung disease (Bernstein et al. 1984) and mild overlap features such as Raynaud's phenomenon, arthritis and sicca syndrome.
Although the beneficial effects of TBI may be short-lived, it can be a useful adjunct to treatment in life-threatening disease where conventional therapy has failed. A case is reported of metastasizing malignant fibrous histiocytoma originating in the lower limbs of a patient with Milroy's disease. This appears to be the first report of this type of tumour arising in a lymphoedematous limb.
Case report
Mr M was diagnosed at the age of 15 as having Milroy's disease. His mother and uncle both suffered from the same condition. No specific treatment for his lymphoedematous legs was given. At the age of 41 he presented with large ulcers over the back of his right calf and foot measuring 12 x 9 inches (31 x 23 cm) in size. These did not respond to conventional conservative treatment as an inpatient, his general condition deteriorated and he became anaemic. In December 1978 he had a subtrochanteric amputation of his right leg; unfortunately histology of the ulcerated areas was not carried out. At the time of his original admission it was also noted that he had a small 'lipoma' on his left trunk, but this was not enlarging and was left alone. He made a good recovery from his amputation and his clinical condition improved dramatically. In 1980 a large subcutaneous swelling was noted in his amputation stump (Figure 1 ). Biopsy of this revealed it to be a malignant fibrous histiocytoma (MFH) and he was admitted for disarticulation of the stump through the hip joint and excision and biopsy of the mass on the left trunk. This latter proved also to be an MFH. He made a good recovery from this operation but seven months later a chest X-ray revealed a mass in the right upper lobe which was presumed to be a metastasis. He was readmitted in 1980 with further anaemia and was found to have developed multiple swellings and ulceration of the left leg, which had a similar appearance to the original lesions on the right. In December 1980 the swellings were excised and primary closure achieved, and this was followed by a course of vincristine and cyclophosphamide. The chest lesion remained unchanged in size radiologically. Six months later further tumours on the left leg required further excision and split-skin grafting. By August 1981 the leg had healed and was clear of local recurrent disease.
In February 1982 increasing dyspnoea necessitated readmission and a chest X-ray revealed a 'Accepted 21 December 1984
